GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » Revenue per Share

Vineet Laboratories (BOM:543298) Revenue per Share : ₹185.22 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories Revenue per Share?

Vineet Laboratories's revenue per share for the three months ended in Dec. 2023 was ₹35.40. Vineet Laboratories's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹185.22.

Warning Sign:

Vineet Laboratories Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Vineet Laboratories was -19.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Vineet Laboratories's Revenue per Share or its related term are showing as below:

BOM:543298's 3-Year Revenue Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: 8.35
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Vineet Laboratories Revenue per Share Historical Data

The historical data trend for Vineet Laboratories's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories Revenue per Share Chart

Vineet Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Revenue per Share
Get a 7-Day Free Trial - - 264.11 207.37 230.28

Vineet Laboratories Quarterly Data
Mar17 Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.38 62.01 40.83 46.98 35.40

Competitive Comparison of Vineet Laboratories's Revenue per Share

For the Chemicals subindustry, Vineet Laboratories's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vineet Laboratories's PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's PS Ratio distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's PS Ratio falls into.



Vineet Laboratories Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Vineet Laboratories's Revenue Per Share for the fiscal year that ended in Mar. 2023 is calculated as

Revenue Per Share (A: Mar. 2023 )=Revenue (A: Mar. 2023 )/Shares Outstanding (Diluted Average) (A: Mar. 2023 )
=2122.933/9.219
=230.28

Vineet Laboratories's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )=Revenue (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=326.47/9.222
=35.40

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹185.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vineet Laboratories  (BOM:543298) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Vineet Laboratories Revenue per Share Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vineet Laboratories (BOM:543298) Business Description

Traded in Other Exchanges
Address
5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074
Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines